This document was generated by the Reference Group to the … · OST 4: Availability of other forms...

This document was generated by the Reference Group to the United Nations on HIV and Injecting Drug Use.

The data included in this report reflect the results of a systematic

search and review of data on a range of indicators reflecting the

extent of services provided to people who inject drugs.

These data have been searched, reviewed and extracted according

to decision rules developed by the Reference Group.

Some data have been adjusted to facilitate estimates of standard

indicators across countries.

Details of the process for searching, grading and including data, along with their interpretation, are detailed in: Mathers B, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick R, et al. HIV prevention, treatment and care for people who inject drugs: A systematic review of global, regional and national coverage. The Lancet 2010. DOI:10.1016/S0140-6736(10)60232-2.

For more information on the Reference Group, please go to: www.IDURefGroup.Com

http://www.idurefgroup.com/

Ukraine (Eastern Europe) Table of Contents

Section Page

Estimated number of people who inject drugs and number of injectors who are livingwith HIV 4

1. Needle and syringe programs (NSPs) 5

NSP 1: Availability of NSPs

NSP 2: Number of NSP sites

NSP 3: Number of pharmacy sites where needles and syringes are available for purchase

NSP 4: Total number of sites where needles and syringes are available

NSP 5: Number of individual IDUs in contact with NSPs in a 12 month period

NSP 6: Number of NSP occasions of service (client contacts) in a 12 month period

NSP 7: Number of needles and syringes distributed by NSPs in a 12 month period

2. Opioid substitution programs (OST) 12

OST 1: Availability of opioid substitution treatment (OST)

OST 2: Availability of methadone maintenance treatment (MMT)

OST 3: Availability of buprenorphine maintenance treatment (BMT)

OST 4: Availability of other forms of agonist OST

OST 5: Dose and duration of MMT

OST 6: Dose and duration of BMT

OST 7: Total number of all sites providing OST

OST 8: Number of sites providing MMT

OST 9: Number of sites providing BMT

OST 10: Number of sites providing other forms of agonist OST

OST 11: Number of all clients in any OST at a single point in time

OST 12: Number of all clients in MMT at a single point in time

OST 13: Number of all clients in BMT at a single point in time

OST 14: Number of all clients in other forms of OST at a single point in time

OST 15: Number of IDUs in any OST at a single point in time

OST 16: Number of IDUs in MMT at a single point in time

OST 17: Number of IDUs in BMT at a single point in time

OST 18: Number of IDUs in other forms of OST at a single point in time

OST 19: Number of all clients receiving any OST in a 12 month period

OST 20: Number of all clients receiving MMT in a 12 month period

OST 21: Number of all clients receiving BMT in a 12 month period

OST 22: Number of all clients receiving other forms of OST in a 12 month period

OST 23: Number of IDUs receiving any OST in a 12 month period

OST 24: Number of IDUs receiving MMT in a 12 month period

1 of 51This report was generated by the Reference Group to the United Nations on HIV and injecting drug use. For details of methods and interpretation, see: Mathers, B., L. Degenhardt, et al. (2010). "HIV prevention, treatment and care for people who inject drugs: A systematic review of global, regional and national coverage." The Lancet. DOI:10.1016/S0140-6736(10)60232-2.


Section PageOST 25: Number of IDUs receiving BMT in a 12 month period

OST 26: Number of IDUs receiving other forms of OST in a 12 month period

3. Other Drug Treatment (ODT) 26

ODT 1: Detoxification

ODT 1.1: Number of sites providing detoxification

ODT 1.2: Number of IDUs receiving detoxification

ODT 1.3: Number of all clients receiving detoxification in a 12 month period and/or at a single point in time

ODT 2: Residential Rehabilitation

ODT 2.1: Number of sites providing residential rehabilitation

ODT 2.2: Number of IDUs in residential rehabilitation

ODT 2.3: Number of all clients in residential rehabilitation

ODT 3: Outpatient psychosocial support, counselling and psychotherapy

ODT 3.1: Number of sites providing outpatient psychosocial support, counselling or psychotherapy

ODT 3.2: Number of IDUs receiving outpatient psychosocial support, counselling or psychotherapy treatment

ODT 3.3: Number of all clients receiving outpatient psychosocial support, counselling or psychotherapy treatment

ODT 4: Peer-based support groups

ODT 4.1: Number of sites providing peer-based support groups

ODT 4.2: Number of IDUs in peer-based support groups

ODT 4.3: Number of all clients in peer-based support groups

ODT 5: Drug treatment (treatment type not specified)

ODT 5.1: Number of sites providing unspecified drug treatment

ODT 5.2: Number of IDUs receiving unspecified drug treatment

ODT 5.3: Number of all clients receiving unspecified drug treatment

ODT 6: Drug treatment in prisons

ODT 6.1: Number of drug treatment sites located in prisons

ODT 6.2: Number of IDUs receiving drug treatment in prisons

ODT 6.3: Number of all clients receiving drug treatment in prisons

ODT 7: Compulsory drug treatment

ODT 7.1: Number of compulsory detention sites for drug use

ODT 7.2: Number of IDUs in compulsory detention sites for drug use

ODT 7.3: Number of all drug users in compulsory detention sites for drug use

4. HIV testing and counselling (T&C) 41

T&C 1: Availability of HIV T&C

T&C 2: Number of sites providing HIV T&C that specifically targets IDUs



Section PageT&C 3: Number of T&C sites providing HIV T& to the general population and also accessible to IDUs

T&C 4: Number of individual IDUs who were tested for HIV in a 12 month period

T&C 5: Percentage of IDUs who were tested for HIV in a 12 month period and who know the result

5. Anti-retro-viral (ARV) treatment 45

ARV 1: Number of sites providing ARV treatment

ARV 2: Number of IDUs receiving ARVs at a single point in time

ARV 3: Restrictions on IDUs' access to ARVs

6. Condoms 48

Condoms 1: Availability of condom programs targeting IDUs

Condoms 2: Number of sites distributing condoms to IDUs

Condoms 3: Number of individual IDUs receiving condoms

Condoms 4: Number of condoms distributed to IDUs


Ukraine (Eastern Europe)

Estimated number of people who inject drugs and number of injectors who are living with HIV

Estimated prevalence of IDU among generalpopulation aged 15-64 years (%)

Low Mid High

0.71 0.90 1.12

Year of IDU prevalence estimate 2009

Reference for IDU prevalence estimate Ukrainian AIDS Center of the Ministry of Health of Ukraine, World HealthOrganization, et al. (2009). National estimate of HIV/AIDS in Ukraine as ofbeginning of 2009. Kyiv, Ukraine.

Estimated prevalence of HIV among people whoinject (%)

Low Mid High

0.80 32.4 67.76

Year of HIV prevalence among IDU estimate 2008

Reference for HIV prevalence among IDU estimate Kobyscha, Y as cited in Sultanov, M. (HIV/AIDS Advisor in Ukraine and Moldova),UNODC. Response to "Ukraine - UN Reference Group - Final Data Check". Kyiv,Ukraine, 2009. Received by the Reference Group to the UN on HIV and InjectingDrug Use on 14 Oct 2009.

General population 15-64 years of age in 2008 32 265 788 (source: UN Population Division, 2009)

Estimated IDU population in 2008 Low Mid High

230 500 291 000 361 000

Estimated number of IDUs living with HIV in 2008 Low Mid High

1853 94 284 244611


Ukraine (Eastern Europe) NSP

1. Needle and syringe programs (NSPs)

NSP 1: Availability of NSPs

Are NSPs available? Yes

Comments

Most recent year of documentation 2009

Reference See references for other NSP indicators

When were NSPs first introduced? 1998

Reference L.Amjadeen, L.Andrushchak, et al. (2005). A review of work with injecting drug users inUkraine in the context of the HIV/AIDS Epidemic. Kyiv.

Are needles and syringes available for purchasefrom pharmacies?

Yes


Reference Apteka. (2009). "Infrastructure pharmaceutical market. Part I: Ukraine as a whole "Retrieved 28 October, 2009, from http://www.apteka.ua/article/6585.



NSP 2: Number of NSP sites

Data reported 985 sites

(1078 sites reported by International HIV/AIDS Alliance Ukraine

223 sites operated by the State Social Service for Youth

22 pharmacies distributing syringes)

Year of reported data 2008

Reference WHO, UNAIDS., et al. (2009). Towards universal access: Scaling up priority HIV/AIDSinterventions in the health sector - progress report 2009. Geneva, WHO.

Skoropatska, J. (Programme Officer: Reporting & Planning), International HIV/AIDS Alliancein Ukraine,. Personal Communication: Response to the "UN HIV and IDU Reference Group:Request to fill data gaps - Ukraine". Kyiv, Ukraine, 2009. Received by the Reference Group tothe UN on HIV and Injecting Drug Use on 6 May 2009.

Dumchev, K. (Technical Officer STI/HIV/AIDS Prevention), WHO Country Office Ukraine,.Personal Communication: Response to the "UN HIV and IDU Reference Group: Request tofill data gaps - Ukraine". Ukraine, 2009. Received by the Reference Group to the UN on HIVand Injecting Drug Use on 15 May 2009.

European Monitoring Centre for Drugs and Drug Addiction. (2008). "CountryOverview:Ukraine." Retrieved 8 Decemeber, 2008, fromhttp://www.emcdda.europa.eu/publications/country-overviews/ua.

Cook, C. and N. Kanaef (2008). Global state of harm reduction 2008: Mapping the responseto drug related HIV and hepatitis C epidemics. London, International Harm ReductionAssociation,.

Samko, M. (Senior Programme Manager), Programmatic Monitoring and Evaluation andDonor Reporting Unit, International HIV/AIDS Alliance in Ukraine. Personal Communication:Response to "Ukraine - UN Reference Group - Final Data Check". Ukraine, 2009. Receivedby the Reference Group to the UN on HIV and Injecting Drug Use.

Svyatyuk, O. (Head of Unit on social and preventive activities), Technical support department,State Social Service for families, children and youth. Personal Communication: Response to"Ukraine - UN Reference Group - Final Data Check". Ukraine, 2009. Received by theReference Group to the UN on HIV and Injecting Drug Use.

Adjustments -

Assumed count of sites are mutually exclusive

Figures taken as range

Final/Adjusted data (to be used as indicatornumerator)

985 - 1323

IDU prevalence estimate (%) Low Mid High

0.71 0.90 1.12

Reference Ukrainian AIDS Center of the Ministry of Health of Ukraine, World Health Organization, et al.(2009). National estimate of HIV/AIDS in Ukraine as of beginning of 2009. Kyiv, Ukraine.

General population 15-64 years of age at year ofreported data

32 265 788 (source: UN Population Division, 2009)

Estimated number of IDUs at year of reporteddata (to be used as indicator denominator)

Low Mid High

230 500 291 000 361 000

INDICATOR: Number of NSP sites per 1000 IDUs Low Mid High

2.73 3.97 5.74



NSP 3: Number of pharmacy sites where needles and syringes are available for purchase

Data reported 22 430 pharmacy sites


Reference Apteka. (2009). "Infrastructure pharmaceutical market. Part I: Ukraine as a whole "Retrieved 28 October, 2009, from http://www.apteka.ua/article/6585.

Adjustments


22 430


0.71 0.90 1.12

Reference 2009




Low Mid High

230 500 291 000 361 000

INDICATOR: Number of pharmacy sites per 1000IDUs

Low Mid High

62.13296398891967 77.07903780068729 97.31019522776573

NSP 4: Total number of sites where needles and syringes are available

Total number (NSP sites + Pharmacy sites)


Reference


(source: UN Population Division, 2009)


Low Mid High

INDICATOR: Total number of sites per 1000 IDUs Low Mid High



NSP 5: Number of individual IDUs in contact with NSPs in a 12 month period

Data reported 94 583 clients accessed NSPs during 2008 provided by the International HIV/AIDSAlliance Ukraine

37 778 individual clients covered by NSP services of the State Social Service forYouth.


Reference Skoropatska, J. (Programme Officer: Reporting & Planning), International HIV/AIDS Alliancein Ukraine,. Personal Communication: Response to the "UN HIV and IDU Reference Group:Request to fill data gaps - Ukraine". Kyiv, Ukraine, 2009. Received by the Reference Group tothe UN on HIV and Injecting Drug Use on 6 May 2009.


Adjustments Assumed count of clients from International HIV/AIDS Alliance Ukraine to be ofindividual clients accessing services

For lower bound of estimate assume all clients accessing State Social Service forYouth had also accessed Alliance services

For upper bound assume counts are mutually exclusive International HIV/AIDSAlliance Ukraine


94 583 - 132 361


0.71 0.90 1.12





Low Mid High

230 500 291 000 361 000

INDICATOR: Percentage of IDUs in contact withNSPs in a 12 month period

Low Mid High

26.2 39.0 57.4



NSP 6: Number of NSP occasions of service (client contacts) in a 12 month period

Data reported 1 257 386 occassions of service at NSPs operated by the International HIV/AIDSAlliance Ukraine


Reference Samko, M. (Senior Programme Manager), Programmatic Monitoring and Evaluation andDonor Reporting Unit, International HIV/AIDS Alliance in Ukraine. Personal Communication:Response to "Ukraine - UN Reference Group - Final Data Check". Ukraine, 2009. Receivedby the Reference Group to the UN on HIV and Injecting Drug Use.

Adjustments


1 257 386


0.71 0.90 1.12





Low Mid High

230 500 291 000 361 000

INDICATOR: Number of NSP occasions of service(client contacts) in a 12 month period per IDU

Low Mid High

3.48 4.32 5.46

NSP 7: Number of needles and syringes distributed by NSPs in a 12 month period

Data reported 8 356 842 syringes distributed

(9 398 456 syringes distributed during 12 month period from sites operated by theInternational HIV/AIDS Alliance Ukraine

616 856 syringes distributed/exchanged by the State Social Service for Youth in2008)


Reference Skoropatska, J. (Programme Officer: Reporting & Planning), International HIV/AIDS Alliancein Ukraine,. Personal Communication: Response to the "UN HIV and IDU Reference Group:Request to fill data gaps - Ukraine". Kyiv, Ukraine, 2009. Received by the Reference Group tothe UN on HIV and Injecting Drug Use on 6 May 2009.


World Health Organisation (2009). Universal Access Unpublished Data.

Adjustments Figures taken as range


8 356 842 - 10 015 312


0.71 0.90 1.12





Low Mid High

230 500 291 000 361 000

INDICATOR: Total number of needles/syringesdistributed in a 12 month period per IDU

Low Mid High

23.15 31.6 43.45


Ukraine NSP

NSP: All documents reviewed

Aceijas, C., M. Hickman, et al. (2007). "Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and CentralAsia.[see comment]." Addiction 102(8): 1244-50.

AIDS Alliance. (2008). "Programme "Overcoming HIV/AIDS epidemic in Ukraine"." Retrieved 16 February, 2009, fromhttp://www.aidsalliance.org.ua/cgi-bin/index.cgi?url=/en/gfund/monitoringandevaluation/results/index.htm.

Apteka. (2009). "Infrastructure pharmaceutical market. Part I: Ukraine as a whole " Retrieved 28 October, 2009, from

AVERT. (2008). "HIV prevention around the world." Retrieved 30 November, 2008, from http://www.avert.org/global-hiv-prevention.htm

AVERT. (2008). "Needle exchanges." Retrieved 30 November, 2008, from http://www.avert.org/needle-exchange.htm

Barcal, K., J. Schumacher, et al. (2005). "A situational picture of HIV/AIDS and injection drug use in Vinnitsya, Ukraine." Harm Reduction Journal

Bega, A. (2007). HIV/AIDS policy in Ukraine. A civil society perspective. A series of reports on HIV/AIDS policy in Nicaragua, Senegal, Ukraine, theUnited States, and Vietnam. New York, Open Society Institute.

Bremen Institute for Drug Research (BISDRO) University of Bremen, Centre for Interdisciplinary Addiction Research (CIAR) University ofHamburg, et al. (2008). Final report on prevention, treatment, and harm reduction services in prison, on reintegration services on release fromprison and methods to monitor/analyse drug use among prisoners.

Burrows, D. (2006). "Advocacy and coverage of needle exchange programs: results of a comparative study of harm reduction programs in Brazil,Bangladesh, Belarus, Ukraine, Russian Federation, and China." Cadernos de Saude Publica 22(4): 871-9.

Burrows, D. (2006). High coverage sites: HIV prevention among injecting drug users in transitional and developing countries: case studies.UNAIDS best practice collection, UNAIDS.

Canadian HIV/AIDS Legal Network (2006). Prison needle exchange: Lessons from a comprehensive review of international evidence and

Central and Eastern European Harm Reduction Network (2007). Hepititis C among injecting drug users in the new EU member states andneighboring countries: Situation, guidelines and recommendations.

Dumchev, K. (Technical Officer STI/HIV/AIDS Prevention), WHO Country Office Ukraine,. Personal Communication: Response to the "UN HIV andIDU Reference Group: Request to fill data gaps - Ukraine". Ukraine, 2009. Received by the Reference Group to the UN on HIV and Injecting DrugUse on 15 May 2009.

Eurasian Harm Reduction Network (2007). Hepatitis C among Injecting Drug Users in the New EU Member States and Neighboring Countries:Situation, Guidelines and Recommendations. Vilnius, Central and Eastern European Harm Reduction Network,.

European Monitoring Centre for Drugs and Drug Addiction. (2008). "Country Overview:Ukraine." Retrieved 8 Decemeber, 2008, fromhttp://www.emcdda.europa.eu/publications/country-overviews/ua.

Human Rights Watch (2006). Rhetoric and Risk: Human Rights Abuses Impeding Ukraine’s Fight against HIV/AIDS. A Human Rights Watch Report18(2(D)). New York, HRW.

Human Rights Watch (2008) World AIDS day: address needs of drug users. Ensure access to HIV prevention and treatment.

International Harm Reduction Development Program (2008). Harm reduction developments 2008. New York.

Jurgens, R. (2007). Interventions to address HIV in prisons: needle and syringe programmes and decontamination strategies. Geneva, WorldHealth Organisation (WHO).

Jurgens, R. and G. Betteridge (2005). "Prisoners who inject drugs: public health and human rights imperatives." Health & Human Rights 8(2): 46-

L.Amjadeen, L.Andrushchak, et al. (2005). A review of work with injecting drug users in Ukraine in the context of the HIV/AIDS Epidemic. Kyiv.

Ministry of Health Ukraine (2008). National Report on Monitoring Progress Towards the UNGASS Declaration of Commitment on HIV/AIDS. Kyiv.

Olexander Yaremenko Ukrainian Institute for Social Research and UNICEF (2008). Core MARA indicators for UNICEF programme: ‘HIV preventionin most-at-risk adolescents (MARA) in Ukraine and South-Eastern Europe’.

Olexander Yaremenko Ukrainian Institute for Social Research, DV8 Research Training and Development, et al. (2006). Risk and protective factorsin the initiation of injecting drug use: Analytical report and strategy paper preventing the Initiation of injecting drug use among vulnerableadolescents and young people. Kyiv.

Samko, M. (Senior Programme Manager), Programmatic Monitoring and Evaluation and Donor Reporting Unit, International HIV/AIDS Alliance inUkraine. Personal Communication: Response to "Ukraine - UN Reference Group - Final Data Check". Ukraine, 2009. Received by the ReferenceGroup to the UN on HIV and Injecting Drug Use.

Skoropatska, J. (Programme Officer: Reporting & Planning), International HIV/AIDS Alliance in Ukraine,. Personal Communication: Response tothe "UN HIV and IDU Reference Group: Request to fill data gaps - Ukraine". Kyiv, Ukraine, 2009. Received by the Reference Group to the UN on


Ukraine NSP

NSP: All documents reviewed

Use on 6 May 2009.

Svyatyuk, O. (Head of Unit on social and preventive activities), Technical support department, State Social Service for families, children andyouth. Personal Communication: Response to "Ukraine - UN Reference Group - Final Data Check". Ukraine, 2009. Received by the ReferenceGroup to the UN on HIV and Injecting Drug Use.

Ukrainian Harm Reduction Association. (2008). "Harm reduction among IDUs." from

UNAIDS (2006). High coverage sites - HIV prevention among injecting drug users in transitional and developing countries. UNAIDS best practicecollection. Geneva.

UNAIDS (2007). Harm reduction to be scaled up in Ukraine, UNAIDS knowledge centre feature story.

WHO and UNAIDS (2008). Progress on implementing the Dublin Declaration on partnership to fight HIV/AIDS in Europe & Central Asia WHO.

WHO, UNAIDS., et al. (2009). Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector - progress report 2009.Geneva, WHO.


Ukraine (Eastern Europe) OST

2. Opioid substitution treatment (OST)

OST 1: Availability of opioid substitution treatment (OST)

Are any forms of agonist OST available? Yes

Comments


Reference See references for other OST indicators

When was agonist OST first available? 2004

Reference Sultanov, M. (HIV/AIDS Advisor in Ukraine and Moldova), UNODC. PersonalCommunication: Response to "Ukraine - UN Reference Group - Final Data Check". Kyiv,Ukraine, 2009. Received by the Reference Group to the UN on HIV and Injecting Drug Useon 14 Oct 2009.

OST 2: Availability of methadone maintenance treatment (MMT)

Is MMT available? Yes

Comments



When was MMT first available? 2008


OST 3: Availability of buprenorphine maintenance treatment (BMT)

Is BMT available? Yes

Comments



When was BMT first available? 2004


OST 4: Availability of other forms of agonist OST

Are other forms of OST available? NO

Comments



When were other forms of OST first available?

Reference



OST 5: Dose and duration of MMT

Average/standard maintenance dose of MMT 61.5 mg - 80 mg

Comments

Year 2009

Reference Ukrainian Institute of Public Health Policy. (2009). "Bi-weekly OST monitoring Report."Retrieved October 1, 2009, from http://www.uiphp.org.ua/ua/home.

World Health Organisation (2009). Global health ATLAS data.

Average/standard duration of MMT (range)

Comments

Year

Reference

OST 6: Dose and duration of BMT

Average/standard maintenance dose of BMT 10.5 mg - 14 mg

Comments

Year 2009


World Health Organisation (2009). Global health ATLAS data.

Average/standard duration of BMT (range)

Comments

Year

Reference

OST 7: Total number of all sites providing OST

Data reported 79 OST sites

100 OST sites in total



Ukrainian Institute of Public Health Policy. (2009). "Bi-weekly OST monitoring Report."Retrieved October 1, 2009, from http://www.uiphp.org.ua/ua/home.

Adjustments Figure taken as range


79 - 100


0.71 0.90 1.12





Low Mid High

230 000 290 000 360 000

INDICATOR: Number of OST sites per 1000 IDUs Low Mid High

0.22 0.31 0.43



OST 8: Number of sites providing MMT

Data reported 77 MMT sites

87 MMT sites

98 MMT sites


Reference Sultanov, M. (HIV/AIDS Advisor), UNODC. Personal Communication: Response to the "UNHIV and IDU Reference Group: Request to fill data gaps - Ukraine". Kyiv, 2009. Received bythe Reference Group to the UN on HIV and Injecting Drug Use on 13 May 2009.

(Unpublished). Combating the Twin Epidemics of HIV/AIDS and Drug Addiction:Opportunities for Progress and Gaps in Scale - A Report of the CSIS Task Force onHIV/AIDS, Center for Strategic and International Studies.


Adjustments Highest and lowest figures taken as a range


77 - 98


0.71 0.90 1.12





Low Mid High

230 000 290 000 360 000

INDICATOR: Number of MMT sites per 1000 IDUs Low Mid High

0.21 0.30 0.43

OST 9: Number of sites providing BMT

Data reported 28 BMT sites


Reference Sultanov, M. (HIV/AIDS Advisor), UNODC. Personal Communication: Response to the "UNHIV and IDU Reference Group: Request to fill data gaps - Ukraine". Kyiv, 2009. Received bythe Reference Group to the UN on HIV and Injecting Drug Use on 13 May 2009.


Adjustments


28


0.71 0.90 1.12





Low Mid High

230 000 290 000 360 000

INDICATOR: Number of BMT sites per 1000 IDUs Low Mid High

0.08 0.10 0.12



OST 10: Number of sites providing other forms of agonist OST

Data reported Other forms of OST not available


Reference Sultanov, M. (HIV/AIDS Advisor in Ukraine and Moldova), UNODC. Personal Communication:Response to "Ukraine - UN Reference Group - Final Data Check". Kyiv, Ukraine, 2009.Received by the Reference Group to the UN on HIV and Injecting Drug Use on 14 Oct 2009.

Adjustments


0


0.71 0.90 1.12





Low Mid High

230 000 290 000 360 000

INDICATOR: Number of sites providing otherforms of OST per 1000 IDUs

Low Mid High

0 0 0



OST 11: Number of all clients in any OST at a single point in time

Data reported 3793 clients in MMT

841 clients in BMT



Adjustments


4634


0.71 0.90 1.12

Reference Mathers, B., L. Degenhardt, et al. (2008). "Global epidemiology of injecting drug use and HIVamong people who inject drugs: a systematic review." The Lancet 372(9651): 1733-1745.


32 181 803 null


Low Mid High

230 000 290 000 360 000

INDICATOR: Ratio of total number of all clients(including IDUs and non-IDUs) on any OST atcensus date : 100 IDUs

Low Mid High

1.29 1.60 2.01

OST 12: Number of all clients in MMT at a single point in time

Data reported 3793 clients on MMT 1 October 2009



Adjustments


3793


0.71 0.90 1.12



32 181 803 null


Low Mid High

230 000 290 000 360 000

INDICATOR: Ratio of total number of all clients(including IDUs and non-IDUs) on MMT at censusdate : 100 IDUs

Low Mid High

1.05 1.31 1.65



OST 13: Number of all clients in BMT at a single point in time

Data reported 841 clients on BMT 1 October 2009



Adjustments


841


0.71 0.90 1.12



32 181 803 null


Low Mid High

230 000 290 000 360 000

INDICATOR: Ratio of total number of all clients(including IDUs and non-IDUs) on BMT at censusdate : 100 IDUs

Low Mid High

0.23 0.29 0.37

OST 14: Number of all clients in other forms of OST at a single point in time

Data reported

Year of reported data

Reference

Adjustments



Reference



Low Mid High

INDICATOR: Ratio of total number of all clients(including IDUs and non-IDUs) on other forms ofOST at census date : 100 IDUs

Low Mid High



OST 15: Number of IDUs in any OST at a single point in time

Data reported 3793 clients in MMT

841 clients in BMT

all clients on OST are IDUs



Sultanov, M. (HIV/AIDS Advisor in Ukraine and Moldova), UNODC. Personal Communication:Response to "Ukraine - UN Reference Group - Final Data Check". Kyiv, Ukraine, 2009.Received by the Reference Group to the UN on HIV and Injecting Drug Use on 14 Oct 2009.

Adjustments


4634


0.71 0.90 1.12



32 181 803 null


Low Mid High

230 000 290 000 360 000

INDICATOR: Percentage of IDUs in OST at asingle point in time

Low Mid High

1.29 1.60 2.01

OST 16: Number of IDUs in MMT at a single point in time

Data reported 3793 clients on MMT 1 October 2009

all clients on MMT are IDUs



Adjustments


3793


0.71 0.90 1.12



32 181 803 null


Low Mid High

230 000 290 000 360 000

INDICATOR: Percentage of IDUs in MMT at asingle point in time

Low Mid High

1.05 1.31 1.65



OST 17: Number of IDUs in BMT at a single point in time

Data reported 841 clients on BMT 1 October 2009




Adjustments


841


0.71 0.90 1.12



32 181 803 null


Low Mid High

230 000 290 000 360 000

INDICATOR: Percentage of IDUs in BMT at asingle point in time

Low Mid High

0.23 0.29 0.37

OST 18: Number of IDUs in other forms of OST at a single point in time

Data reported null

Year of reported data null

Reference null

Adjustments null


null


0.71 0.90 1.12



null


Low Mid High

null null null

INDICATOR: Percentage of IDUs in other forms ofOST at a single point in time

Low Mid High

null null null



OST 19: Number of all clients receiving any OST in a 12 month period

Data reported OST available but number of clients on OST not known



Adjustments


NK


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Ratio of total number of all clients(including IDUs and non-IDUs) on any OST in a 12month period : 100 IDUs

Low Mid High

NK NK NK

OST 20: Number of all clients receiving MMT in a 12 month period

Data reported MMT available but number of clients not known



Adjustments


NK


0.71 0.90 1.12



32 181 803 null


Low Mid High

230 000 290 000 360 000

INDICATOR: Ratio of total number of all clients(including IDUs and non-IDUs) on MMT in a 12month period : 100 IDUs

Low Mid High

NK NK NK



OST 21: Number of all clients receiving BMT in a 12 month period

Data reported BMT available but number of clients not known



Sultanov, M. (HIV/AIDS Advisor in Ukraine and Moldova), UNODC. PersonalCommunication: Response to "Ukraine - UN Reference Group - Final Data Check". Kyiv,Ukraine, 2009. Received by the Reference Group to the UN on HIV and Injecting Drug Useon 14 Oct 2009.

Adjustments


NK


0.71 0.90 1.12



32 181 803 null


Low Mid High

230 000 290 000 360 000

INDICATOR: Ratio of total number of all clients(including IDUs and non-IDUs) on BMT in a 12month period : 100 IDUs

Low Mid High

NK NK NK

OST 22: Number of all clients receiving other forms of OST in a 12 month period

Data reported


Reference

Adjustments



Reference



Low Mid High

INDICATOR: Ratio of total number of all clients(including IDUs and non-IDUs) on other forms ofOST in a 12 month period : 100 IDUs

Low Mid High



OST 23: Number of IDUs receiving any OST in a 12 month period

Data reported OST available but number of IDU on OST not known




Adjustments


NK


0.71 0.90 1.12



32 181 803 null


Low Mid High

230 000 290 000 360 000

INDICATOR: Percentage of IDUs receiving OST ina 12 month period

Low Mid High

NK NK NK

OST 24: Number of IDUs receiving MMT in a 12 month period

Data reported MMT available but number of IDU receiving MMT during 12 month period notknown



Sultanov, M. (HIV/AIDS Advisor in Ukraine and Moldova), UNODC. PersonalCommunication: Response to "Ukraine - UN Reference Group - Final Data Check". Kyiv,Ukraine, 2009. Received by the Reference Group to the UN on HIV and Injecting Drug Useon 14 Oct 2009.

Adjustments


NK


0.71 0.90 1.12



32 181 803 null


Low Mid High

230 000 290 000 360 000

INDICATOR: Percentage of IDUs receiving MMT ina 12 month period

Low Mid High

NK NK NK



OST 25: Number of IDUs receiving BMT in a 12 month period

Data reported BMT available but number of IDUs receiving BMT during 12 month period not know




Adjustments


NK


0.71 0.90 1.12



32 181 803 null


Low Mid High

230 000 290 000 360 000

INDICATOR: Percentage of IDUs receiving BMT ina 12 month period

Low Mid High

NK NK NK

OST 26: Number of IDUs receiving other forms of OST in a 12 month period

Data reported null

Year of reported data null

Reference null

Adjustments null


null


0.71 0.90 1.12



null null


Low Mid High

null null null

INDICATOR: Percentage of IDUs receiving otherforms of OST at a single point in time

Low Mid High

null null null


Ukraine OST

OST: All documents reviewed

(2007). "In Ukraine, the introduction of substitution therapy progarms for drug addicts meets current legislation and WHO guidelines." Retrieved23 March, 2009, from <http://www.kmu.gov.ua/control/publish/article?art_id=78717885>.

(2008). "MOH figures for first half of 2008." Retrieved 23 March, 2009, from<http://zapitay.in.ua/index.php?option=com_content&task=blogsection&id=8&Itemid=59&lang=ua>.

(2009). "132 addicts receive methadone Nukolayivi ST." Retrieved 23 March, 2009, from<http://zapitay.in.ua/index.php?option=com_content&task=blogsection&id=8&Itemid=59&lang=ua>.

(2009). "Started PTA Methadone Progarm in Lugansk." Retrieved 23 March, 2009, from<http://zapitay.in.ua/index.php?option=com_content&task=blogsection&id=8&Itemid=59&lang=ua>


AVERT. (2008). "HIV and AIDS in Russian Eastern Europe & Central Asia." Retrieved 30 November, 2008, from http://www.avert.org/aids-russia.htm

Barrett, D., R. Lines, et al. (2008). Recalibrating the Regime: The Need for a Human Rights-based Approach to International Drug Policy. Oxford,Human Rights Watch, the International Harm Reduction Association and the Canadian HIV/AIDS Legal Network. .


Bruce, R. D., S. Dvoryak, et al. (2007). "HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUsin Ukraine--programme description and policy implications." International Journal of Drug Policy 18(4): 326-8.


Central and Eastern European Harm Reduction Network (2007). Hepititis C among injecting drug users in the new EU member states andneighboring countries: Situation, guidelines and recommendations.

Committee for combating HIV/AIDS and other socially dangerous diseases. (2009). "Information on the situation of HIV/AIDS in Ukraine."Retrieved 23 March, 2009, from <http://www.stop-aids.org.ua/index.php?option=com_content&view=article&id=86:2009-01-24-20-01-48&catid=52:2009-01-24-20-05-26&Itemid=13>.

Csete, J. and D. Wolfe (2007). Closed to Reason: The International Narcotics Control Board and HIV/AIDS. Toronto and New York, CanadianHIV/AIDS Legal Network and the International Harm Reduction Development Program of the Open Society Institute.


Eurasian Harm Reduction Network, ECCB, et al. (2008). Substitution therapy in 9 countries in Eastern Europe and Central Asia.

European AIDS Treatment Group (2008). Antiretroviral treatment for injecting drug users in Central and Eastern Europe.



Human Rights Watch (2008) World AIDS day: address needs of drug users. Ensure access to HIV prevention and treatment.

International AIDS Society (2008). Expanding access to opioid substitution therapy for injecting drug users in Eastern Europe and Central Asia.IAS Yalta Scientific Leadership Summit.

International AIDS Society (2008). Opioid substitution therapy in selected countries of East European and Central Asia.

International Harm Reduction Association (2008). Harm Reduction and Human Rights: The Global Response to Injection-Driven HIV Epidemics:

International Harm Reduction Association (IHRA) (2007). Conference abstracts book. 18th International Conference on the Reduction of DrugRelated Harm, Warsaw, Poland.

International Harm Reduction Development Program (2008). Harm reduction developments 2008. New York.

Joint United Nations Programme on HIV/AIDS (UNAIDS) (2005). AIDS epidemic update. Geneva, Joint United Nations Programme on HIV/AIDS(UNAIDS) and the World Health Organisation (WHO).

Klepikov, A. (2006). "Fighting HIV/AIDS in Ukraine." Retrieved 8/12/2008, 2008, from<http://www.theglobalfund.org/cn/savinglives/ukraine/hiv2/transcript_en/?lang=cn>


Ukraine OST

OST: All documents reviewed

Lazarus, J. (2006). Ukraine: Reduction of drug-related harm - National conference on the reduction of drug-related harm. CD News - QuarterlyCommunicable Disease Report,. Copenhagen: 2.


Ministry of Health Ukraine (2008). National Report: Implementation of decisions declaration about dedication wrestling since HIV/AIDS. Kyiv.


Open Society Institute and Government fo Canada through the Canadian International Development Agency (2008). Treatment of drug addictionin Ukraine and its evaluation efficiency.

Sidyak, S. Personal Communication: Response to the "UN HIV and IDU Reference Group: Request to fill data gaps - Ukraine". 2009. Received bythe Reference Group to the UN on HIV and Injecting Drug Use on 6 May 2009.

Sultanov, M. (HIV/AIDS Advisor), UNODC. Personal Communication: Response to the "UN HIV and IDU Reference Group: Request to fill data gaps- Ukraine". Kyiv, 2009. Received by the Reference Group to the UN on HIV and Injecting Drug Use on 13 May 2009.

Ukrainian Institute of Public Health Policy. (2009). "Summary of patients substitution maintenance treatment programs in Ukraine (as at15.02.09)." Retrieved 23 March, 2009, from <http://www.uiphp.org.ua/project.htm>.

Ukrainian Medical and Monitoring Cneter on Alcohol & Drugs. "Current drug situation in Ukraine as of 01.01.2008." Retrieved 23 March, 2009,from <http://damonitoring.net.ua/uk/report2008/>.

UNAIDS (2007). Harm reduction to be scaled up in Ukraine, UNAIDS knowledge centre feature story.

UNAIDS. (2008). "Making a difference: UNAIDS in Ukraine." fromhttp://www.unaids.org/en/KnowledgeCentre/Resources/FeatureStories/archive/2008/20080108_Ukraine.asp



Ukraine (Eastern Europe) ODT

3. Other drug treatment (ODT)

ODT 1 - Detoxification

ODT 1.1: Number of sites providing detoxification

Is detoxification available? Yes

Number of sites - data reported Inpatient & Outpatient detox provided at all 47 territorial narcological facilities, 4narcological hospitals, some mental healthcare facilities and rural outpatient units


Reference European Monitoring Centre for Drugs and Drug Addiction. (2008). "CountryOverview:Ukraine." Retrieved 8 Decemeber, 2008, fromhttp://www.emcdda.europa.eu/publications/country-overviews/ua.

Adjustments


> 51


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Number of detoxification sites per1000 IDUs

Low Mid High

0.14 0.18 0.22



ODT 1.2: Number of IDUs receiving detoxification

Data reported 54 872 drug users received detoxification treatment in 2008, 92% of these wereopiate injectors


Reference National Drug Observatory within the National Center for Health Management (2009). cited inSultanov, M. (HIV/AIDS Advisor in Ukraine and Moldova), UNODC. Response to "Ukraine -UN Reference Group - Final Data Check". Kyiv, Ukraine, 2009. Received by the ReferenceGroup to the UN on HIV and Injecting Drug Use on 14 Oct 2009.

Republican Narcological Dispensary (2009). cited in Sultanov, M. (HIV/AIDS Advisor inUkraine and Moldova), UNODC. Response to "Ukraine - UN Reference Group - Final DataCheck". Kyiv, Ukraine, 2009. Received by the Reference Group to the UN on HIV andInjecting Drug Use on 14 Oct 2009.

Adjustments

Final/Adjusted data for 12 month period (to beused as indicator numerator)

50 482

Final/Adjusted data for single point in time (to beused as indicator numerator)

NK


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Percentage of IDUs in detoxificationin a 12 month period

Low Mid High

13.98 17.35 21.90

INDICATOR: Percentage of IDUs in detoxificationat a single point in time

Low Mid High

NK NK NK



ODT 1.3: Number of all clients receiving detoxification in a 12 month period and/or at a singlepoint in timeData reported 92 % of 59 643 drug disorder treatment cases registered were for detoxification



Adjustments Derived estimate from reported data


54 872


NK


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Ratio of number of all clients indetoxification in a 12 month period : number ofIDUs

Low Mid High

0.15 0.19 0.24

INDICATOR: Ratio of number of all clients indetoxification at a single point in time : number ofIDUs

Low Mid High

NK NK NK



ODT 2 - Residential rehabilitation

ODT 2.1: Number of sites providing residential rehabilitation

Is residential rehabilitation present? Yes

Number of sites - data reported 50 Inpatient rehabilitation programmes centres

20 Therapeutic communities

40 inpatient programmes of spiritual psychotherapy and religious rehabilitation



Adjustments Assumed counts are mutually exclusive


110


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Number of residential rehabilitationsites per 1000 IDUs

Low Mid High

0.30 0.38 0.48

ODT 2.2: Number of IDUs in residential rehabilitation

Data reported Residential rehabilitation present but number not known



Adjustments


NK


NK


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Percentage of IDUs in residentialrehabilitation in a 12 month period

Low Mid High

NK NK NK

INDICATOR: Percentage of IDUs in residentialrehabilitation at a single point in time

Low Mid High

NK NK NK



ODT 2.3: Number of all clients in residential rehabilitation

Data reported Residential rehabilitation present but number not known



Adjustments


NK


NK


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Ratio of number of all drug users inresidential rehabilitation in a 12 month period :number of IDUs

Low Mid High

NK NK NK

INDICATOR: Ratio of number of all drug users inresidential rehabilitation at a single point in time :number of IDUs

Low Mid High

NK NK NK



ODT 3 - Outpatient psychosocial support, counselling and psychotherapy

ODT 3.1: Number of sites providing outpatient psychosocial support, counselling orpsychotherapy treatmentIs outpatient psychosocial support, counsellingor psychotherapy present?

Yes

Number of sites - data reported Psychosocial support and counselling present but number not known



Adjustments


NK


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Number of outpatient psychosocialsupport, counselling or psychotherapy sites per1000 IDUs

Low Mid High

NK NK NK

ODT 3.2: Number of IDUs receiving outpatient psychosocial support, counselling orpsychotherapy treatmentData reported Psychosocial support and counselling present but number not known



Adjustments


NK


NK


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Percentage of IDUs in outpatientpsychosocial support, counselling orpsychotherapy in a 12 month period

Low Mid High

NK NK NK

INDICATOR: Percentage of IDUs receivingoutpatient psychosocial support, counselling orpsychotherapy at a single point in time

Low Mid High

NK NK NK



ODT 3.3: Number of all clients receiving outpatient psychosocial support, counselling orpsychotherapy treatmentData reported Psychosocial support and counselling present but number not known



Adjustments


NK


NK


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Ratio of number of all drug users inoutpatient psychosocial support, counselling orpsychotherapy in a 12 month period : number ofIDUs

Low Mid High

NK NK NK

INDICATOR: Ratio of number of all drug users inoutpatient psychosocial support, counselling orpsychotherapy at a single point in time : numberof IDUs

Low Mid High

NK NK NK



ODT 4 - Peer-based support groups

ODT 4.1: Number of peer-based support groups sites

Are Peer-based support groups present? Yes

Number of sites - data reported 74 NA meetings per week


Reference Narcotics Anonymous World Services (2009). Quadrennial report for non-governmentalorganizations - July 2009.

Adjustments Assumed each meeting per week occurs at a separate location


74


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Number of peer-based supportgroups sites per 1000 IDUs

Low Mid High

0.20 0.25 0.32

ODT 4.2: Number of IDUs in peer-based support groups

Data reported Narcotics Anonymours present but number not known



Adjustments


NK


NK


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Percentage of IDUs in peer-basedsupport groups in a 12 month period

Low Mid High

NK NK NK

INDICATOR: Percentage of IDUs in peer-basedsupport groups at a single point in time

Low Mid High

NK NK NK



ODT 4.3: Number of all clients in peer-based support groups

Data reported Narcotics Anonymours present but number not known



Adjustments


NK


NK


0.71 0.90 1.12



32 265 788 null


Low Mid High

230 500 291 000 361 000

INDICATOR: Ratio of number of all drug users inpeer-based support groups in a 12 month period :number of IDUs

Low Mid High

NK NK NK

INDICATOR: Ratio of number of all drug users inpeer-based support groups at a single point intime : number of IDUs

Low Mid High

NK null null



ODT 5 - Drug treatment (treatment type not specified)

ODT 5.1: Number of drug treatment sites (treatment type not specified)

Type of drug treatment available

Number of sites - data reported


Reference

Adjustments



Reference



Low Mid High

INDICATOR: Number of drug treatment sites per1000 IDUs

Low Mid High

ODT 5.2: Number of IDUs in drug treatment (treatment type not specified)

Data reported


Reference

Adjustments




Reference



Low Mid High

INDICATOR: Percentage of IDUs in drug treatmentnot specified/drug treatment combined in a 12month period

Low Mid High

INDICATOR: Percentage of IDUs in drug treatmentnot specified/drug treatment combined at a singlepoint in time

Low Mid High



ODT 5.3: Number of all clients in drug treatment (treatment type not specified)

Data reported


Reference

Adjustments




Reference



Low Mid High

INDICATOR: Ratio of number of all drug users indrug treatment not specified/drug treatmentcombined in a 12 month period : number of IDUs

Low Mid High

INDICATOR: Ratio of number of all drug users indrug treatment not specified/drug treatmentcombined at a single point in time : number ofIDUs

Low Mid High



ODT 6 - Drug treatment in prisons

ODT 6.1: Number of prison drug treatment sites

Type of drug treatment in prisons?



Reference

Adjustments

Final/Adjusted data

ODT 6.2: Number of IDUs in drug treatment in prisons

Data reported


Reference

Adjustments

Final/Adjusted data for 12 month period

Final/Adjusted data for single point in time

ODT 6.3: Number of all clients in drug treatment in prisons

Data reported


Reference

Adjustments

Final/Adjusted data for 12 month period

Final/Adjusted data for single point in time



ODT 7 - Compulsory detention as response to drug use

ODT 7.1: Number of compulsory detention sites for drug use



Reference

Adjustments



Reference



Low Mid High

INDICATOR: Number of compulsory detentionsites for drug use per 1000 IDUs

Low Mid High

ODT 7.2: Number of IDUs in compulsory detention sites for drug use

Data reported


Reference

Adjustments




Reference



Low Mid High

INDICATOR: Percentage of IDUs in compulsorydetention in closed settings in a 12 month period

Low Mid High

INDICATOR: Percentage of IDUs in compulsorydetention in closed settings at a single point intime

Low Mid High



ODT 7.3: Number of all drug users in compulsory detention sites for drug use

Data reported


Reference

Adjustments




Reference



Low Mid High

INDICATOR: Ratio of all drug users in compulsorydetention in closed settings in a 12 month period: number of IDUs

Low Mid High

INDICATOR: Ratio of all drug users in compulsorydetention in closed settings at a single point intime : number of IDUs

Low Mid High


Ukraine ODT

ODT: All documents reviewed


Barrett, D., R. Lines, et al. (2008). Recalibrating the Regime: The Need for a Human Rights-based Approach to International Drug Policy. Oxford,Human Rights Watch, the International Harm Reduction Association and the Canadian HIV/AIDS Legal Network. .



Des Jarlais, D., T. Perlis, et al. (2006). "Using standardized methods for research on HIV and injecting drug use in developing/transitionalcountries: case study from the WHO Drug Injection Study Phase II." BMC Public Health 6(1): 54.



Joint United Nations Programme on HIV/AIDS (UNAIDS) (2005). AIDS epidemic update. Geneva, Joint United Nations Programme on HIV/AIDS(UNAIDS) and the World Health Organisation (WHO).


National Drug Observatory within the National Center for Health Management (2009). cited in Sultanov, M. (HIV/AIDS Advisor in Ukraine andMoldova), UNODC. Response to "Ukraine - UN Reference Group - Final Data Check". Kyiv, Ukraine, 2009. Received by the Reference Group to theUN on HIV and Injecting Drug Use on 14 Oct 2009.; Republican Narcological Dispensary (2009). cited in Sultanov, M. (HIV/AIDS Advisor in Ukraineand Moldova), UNODC. Response to "Ukraine - UN Reference Group - Final Data Check". Kyiv, Ukraine, 2009. Received by the Reference Group tothe UN on HIV and Injecting Drug Use on 14 Oct 2009.


Open Society Institute and Government fo Canada through the Canadian International Development Agency (2008). Treatment of drug addictionin Ukraine and its evaluation efficiency.

Ukrainian Medical and Monitoring Cneter on Alcohol & Drugs. "Current drug situation in Ukraine as of 01.01.2008." Retrieved 23 March, 2009,from <http://damonitoring.net.ua/uk/report2008/>.



Ukraine (Eastern Europe) T&C

4. HIV testing and counselling (T&C)

T&C 1: Availability of HIV T&C

Is T&C available? Yes

Most recent year of data 2008

Reference Ukrainian Harm Reduction Association. (2008). "Harm reduction among IDUs." from<http://uhra.org.ua//index.php?option=com_frontpage&Itemid=1>.

UNAIDS (2008). Eastern Europe and Central Asia mapping prevention interventions in theCIS region.

T&C 2: Number of sites providing HIV T&C specifically targeting IDUs

Data reported 81 VCT sites for IDUs by International HIV/AIDS Alliance

223 fixed sites under the state social support centres




Adjustments


304


0.71 0.90 1.12





Low Mid High

230 000 290 000 360 000

INDICATOR: Number of targeted T&C sites per1000 IDUs

Low Mid High

0.84 1.05 1.32



T&C 3: Number of sites providing HIV T&C sites to the general population and also accessible toIDUsData reported 111 sites by International HIV/AIDS Alliance

223 sites under the state social support centres

679 sites by AIDS centre




Valeriy Kester, National AIDS Monitoring and Evaluation Centre.

Adjustments


1013


0.71 0.90 1.12





Low Mid High

230 000 290 000 360 000

INDICATOR: Number of all T&C sites per 1000IDUs

Low Mid High

2.81 3.49 4.40



T&C 4: Number of Individual IDUs who were tested for HIV in 12 month period

Data reported 35 748 IDUs tested by AIDS Centres

55 545 IDUs tested by International HIV/AIDS Alliance

6002 clients tested by State social support centers


Reference Svyatyuk, O. (Head of Unit on social and preventive activities), Technical support department,State Social Service for families, children and youth. Personal Communication: Response to"Ukraine - UN Reference Group - Final Data Check". Ukraine, 2009. Received by theReference Group to the UN on HIV and Injecting Drug Use.

Samko, M. (Senior Programme Manager), Programmatic Monitoring and Evaluation andDonor Reporting Unit, International HIV/AIDS Alliance in Ukraine. Personal Communication:Response to "Ukraine - UN Reference Group - Final Data Check". Ukraine, 2009. Receivedby the Reference Group to the UN on HIV and Injecting Drug Use.

Ministry of Health of Ukraine (2009). HIV infection in Ukraine Newsletter Number 13.

Adjustments


97 295


0.71 0.90 1.12





Low Mid High

230 500 291 000 361 000

INDICATOR: Percentage of individual IDUsaccessing T&Cs in a 12 month period

Low Mid High

26.95 33.43 42.21

T&C 5: Percentage of IDUs who were tested for HIV in a 12 month period and who know theresultYear of reported data 2007

Reference UNAIDS (2008). Report on the global AIDS epidemic. Geneva, UNAIDS: 362.

Data reported for both male and female IDUs 29% IDUs received an HIV test in the last 12 months and know their results

Adjustments

Final/Adjusted data 29%

Data reported for male IDUs 29% male IDUs received an HIV test in the last 12 months and know their results

Adjustments


Data reported for female IDUs 30% female IDUs received an HIV test in the last 12 months and know theirresults

Adjustments



Ukraine T&C

T&C: All documents reviewed




Ministry of Health of Ukraine (2009). HIV infection in Ukraine Newsletter Number 13.


Ministry of Health Ukraine (2008). National Report: Implementation of decisions declaration about dedication wrestling since HIV/AIDS. Kyiv.





UNAIDS (2008). Eastern Europe and Central Asia mapping prevention interventions in the CIS region.

UNAIDS (2008). Report on the global AIDS epidemic. Geneva, UNAIDS: 362.



Ukraine (Eastern Europe) ARV

5. Anti-retro-viral (ARV) treatment

ARV 1: Number of sites providing ARV treatment

Data reported 248 sites



Adjustments


248


0.71 0.90 1.12





Low Mid High

230 000 290 000 360 000

HIV among IDU prevalence estimate (%) Low Mid High

0.80 32.40 67.76


Upper and lower bounds of range are estimates only, these were calculated as per themethods outlined in Mathers et al 2008.

Estimated number of HIV positive IDUs at year ofreported data (to be used as indicator

Low Mid High

1849 93 960 243933

INDICATOR: Number of ARV treatment sites per1000 IDUs

Low Mid High

0.69 0.86 1.08

INDICATOR: Number of ARV treatment sites per1000 IDUs living with HIV

Low Mid High

1.02 2.64 134.16


Ukraine (Eastern Europe) ARV

ARV 2: Number of IDUs receiving ARVs at a single point in time

Data reported 93 IDUs on OST are on ART. These 93 IDUs represent 5% of all IDUs on ART


Reference WHO and UNAIDS (2008). Progress on implementing the Dublin Declaration on partnershipto fight HIV/AIDS in Europe & Central Asia WHO.

Adjustments Calculated the total number of IDUs on ART


1860


0.71 0.90 1.12





Low Mid High

231 500 292 000 362 500

HIV among IDU prevalence estimate (%) Low Mid High

0.80 32.40 67.76


Upper and lower bounds of range are estimates only, these were calculated as per themethods outlined in Mathers et al 2008.

Estimated number of HIV positive IDUs at year ofreported data (to be used as indicatordenominator)

Low Mid High

1861 94 608 245627

INDICATOR: Ratio of IDUs on ART: 100 IDUsliving with HIV

Low Mid High

0.76 1.97 99.97

ARV 3: Restrictions on IDUs' access to ARVs

Do restrictions exist which limit IDUs' access toARV treatment?


Reference


Ukraine ARV

ARV: All documents reviewed

Aceijas, C., E. Oppenheimer, et al. (2006). "Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year beforethe end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5")." Addiction 101(9): 1246-53.





Donoghoe, M. C., A. R. Bollerup, et al. (2007). "Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHOEuropean Region 2002-2004." International Journal of Drug Policy 18(4): 271-80.

European AIDS Treatment Group (2008). Antiretroviral treatment for injecting drug users in Central and Eastern Europe.


International Harm Reduction Association (IHRA) (2007). Conference abstracts book. 18th International Conference on the Reduction of DrugRelated Harm, Warsaw, Poland.


Volodymyr Kurpita All-Ukrainian Network of PLWH (2009). Introduction of integrating HIV/AIDS Treatment and Care for IDU - Ukrainianexperience. Windhoek, Namibia.


WHO, UNAIDS., et al. (2009). Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector - progress report 2009.Geneva, WHO.


Ukraine (Eastern Europe) Condoms

6. Condoms

Condoms 1: Availability of condom programs targeting IDUs

Are condom programs targeting IDUs available? Yes

Comments

Year 2008

Reference See references for other Condom indicators

Condoms 2: Number of sites distributing condoms to IDUs

Data reported All NGP and state operated NSP sites (n= 1301) distribute condoms



Samko, M. (Senior Programme Manager), Programmatic Monitoring and Evaluation andDonor Reporting Unit, International HIV/AIDS Alliance in Ukraine. Personal Communication:Response to "Ukraine - UN Reference Group - Final Data Check". Ukraine, 2009. Receivedby the Reference Group to the UN on HIV and Injecting Drug Use.\

Adjustments


1301


0.71 0.90 1.12





Low Mid High

230 000 290 000 360 000

INDICATOR: Number of condom distribution sitestargeting IDU per 1000 IDUs

Low Mid High

3.61 4.49 5.66



Condoms 3: Number of individual IDUs receiving condoms

Data reported 94 500 IDUs received condoms from NSP sites operated by International HIV/AIDSAlliance sites

37 778 IDUs received condoms from NSP sites operated by State Social Servicefor families, children and youth.




Adjustments


132 278


0.71 0.90 1.12





Low Mid High

230 500 291 000 361 000

INDICATOR: Percentage of IDUs receivingcondoms in a 12 month period

Low Mid High

36.64 45.46 57.39



Condoms 4: Number of condoms distributed to IDUs

Data reported 4 158 270 condoms distributed to IDUs by International HIV/AIDS Alliance sites

680004 condoms distributed by NSP services operated by State Social Service forfamilies, children and youth.




Adjustments


4 838 274


0.71 0.90 1.12





Low Mid High

230 500 291 000 361 000

INDICATOR: Total number of condomsdistributed per 12 month period per IDU

Low Mid High

13.40 16.63 20.99


Ukraine Condoms

Condoms: All documents reviewed












UNAIDS (2008). Eastern Europe and Central Asia mapping prevention interventions in the CIS region.


This document was generated by the Reference Group to the … · OST 4: Availability of other forms...

Documents

Transcript of This document was generated by the Reference Group to the … · OST 4: Availability of other forms...